Musaeva Lola Guraevna Senior Lecturer of the Department
of Clinical Pharmacology TMA
Phone: 150-97-55
Е-mail: lola.musaeva@tma.uz
Education:
1992-1998 – Student of the Second Tashkent State Medical Institute (diploma medical case)
1998 –2000 – Clinical resident of the Department of Clinical Pharmacology of the Second Tashkent State Medical Institute2000 –2003 – Post-graduate student of the Department of Clinical Pharmacology of the Second Tashkent State Medical Institute2004 – Defended her thesis for a master’s degree, Tashkent (candidate of medical sciences)
Work experience:
1992-1998 – Student of the Second Tashkent State Medical Institute
1998-2000 – Clinical resident of the Department of Clinical Pharmacology of the Second Tashkent State Medical Institute2000-2003 – Post-graduate student of the Department of Clinical Pharmacology of the Second Tashkent State Medical Institute2003-2005 – Assistant of the Department of Clinical Pharmacology of the Second Tashkent State Medical Institute2005-2017 – Assistant of the Department of Clinical Pharmacology of the Tashkent Medical Academy2017 – Senior lecturer of the Department of Clinical Pharmacology of the Tashkent Medical Academy
Scientific activity:2004 г. – Defended her thesis on the topic: “Comparative evaluation of the cytoprotective effect of some antioxidants on the mucous gastroduodenal zone in case of peptic ulcer”, Tashkent.
The main areas of practice:
Rational use of medicines in the treatment of diseases of internal organs.
The main directions of scientific activity:
The study of some pathogenetic mechanisms in the development of various pathological conditions and the development of optimal schemes of pharmacotherapy.
The main scientific works for the last 5 years:Articles and theses:
· State of the oxidatitresve stress in the gastric mucosa in using standard schemes of antiulcer quadruple therapy. “Therapeutic Bulletin of Uzbekistan” No. 4, 2014. P.96.· Features of the pharmacodynamic effect of antiulcer drugs on the activity of enzymes of the monooxygenase system in the gastric mucosa. “Therapeutic Bulletin of Uzbekistan” No. 4, 2014. P.111.· Pharmacodynamic effects of drugs and standard regimens of therapy of the second line of peptic ulcer on some indices of aggression in the gastric mucosa. «International scientific review», Boston USA, 7-8 april 2016, № 4. Р. 205-211.· The effectiveness of some hepatoprotectors and their combinations on the effect on the content of cytolysis and cholestasis enzymes in the blood of animals with chronic hepatitis. «International scientific review, Boston USA», 7-8 april 2016, №4. Р. 221-224.· Influence of indomethacin on the level of acid-forming function of the stomach in patients with rheumatoid arthritis and osteoporosis. The 1st Congress of Rheumatologists of Uzbekistan, 2016, p. 237.· Clinical significance of the mucosal barrier of the stomach in patients with chronic obstructive pulmonary disease. Russian scientific research journal “Scientific Research” in 2016, No. 8 (9). C.37-43.· Some mechanisms of cytoprotection disorders in the gastric mucosa in chronic obstructive pulmonary diseases. “Therapeutic Bulletin of Uzbekistan”, 2016 No. 4, P.77.
Ўзбекистон терапия ахборотномаси
International scientific review 4 (14) (1)
